stooocks.com

Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.

ChenMed, LLC

United States ยท Privately owned

ChenMed runs primary care clinics for older adults on Medicare, especially Medicare Advantage plans, and gets paid a fixed amount per patient to keep them healthy.

ChenMed runs primary care clinics for older adults on Medicare, mostly people enrolled in Medicare Advantage plans. Its patients are typically in their 70s and 80s, often with several chronic conditions and modest incomes, and the company's pitch is simple: give them far more attention than a typical doctor's office would.

The model works like this. Instead of billing for each visit, ChenMed is paid a fixed monthly fee per patient by the health plan, a setup known as value-based or capitated care. That flips the usual incentive. A doctor paid per test and per procedure makes more by doing more; ChenMed makes more by keeping people out of the hospital. So its clinics are built for heavy contact: small patient panels per doctor, long visits, same-day appointments, and a care team of nurses and specialists who chase down problems early. The company has said its patients spend significantly fewer days in the hospital than comparable seniors, and that is the core of the business. The customer who actually pays is the health plan โ€” typically a Medicare Advantage insurer โ€” not the patient. ChenMed gets a slice of the premium the plan receives for each member, keeps whatever it doesn't spend on care, and pockets the difference. That means its real customers are insurers who want a partner that keeps their members healthy and their costs down.


ChenMed began with a single clinic in Miami opened by internist Christopher Chen in the 1980s, and it grew slowly for years before expanding across the South and Midwest under brands like JenCare. The economics are attractive but delicate: the margin is the gap between the fixed fee and the cost of care, so a sicker-than-expected patient group can wipe out profits. The bigger risk is that the whole model depends on Medicare Advantage staying generous, since payment rates and risk-adjustment rules set by the government flow straight through to ChenMed's revenue.

Saved answer ยท last researched 15 Nov 2026